Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
177.38
+1.49 (0.85%)
Feb 17, 2026, 4:00 PM EST - Market closed

BDX Revenue

Becton, Dickinson and Company had revenue of $5.25B in the quarter ending December 31, 2025, with 1.63% growth. This brings the company's revenue in the last twelve months to $21.92B, up 6.22% year-over-year. In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B with 8.24% growth.

Revenue (ttm)
$21.92B
Revenue Growth
+6.22%
P/S Ratio
2.32
Revenue / Employee
$304,500
Employees
72,000
Market Cap
50.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202521.84B1.66B8.24%
Sep 30, 202420.18B806.00M4.16%
Sep 30, 202319.37B502.00M2.66%
Sep 30, 202218.87B-261.00M-1.36%
Sep 30, 202119.13B3.06B19.02%
Sep 30, 202016.07B-1.22B-7.03%
Sep 30, 201917.29B1.31B8.18%
Sep 30, 201815.98B3.89B32.17%
Sep 30, 201712.09B-390.00M-3.12%
Sep 30, 201612.48B2.20B21.41%
Sep 30, 201510.28B1.84B21.74%
Sep 30, 20148.45B392.00M4.87%
Sep 30, 20138.05B346.00M4.49%
Sep 30, 20127.71B124.00M1.64%
Sep 30, 20117.58B459.62M6.45%
Sep 30, 20107.12B137.66M1.97%
Sep 30, 20096.99B89.10M1.29%
Sep 30, 20086.90B614.78M9.79%
Sep 30, 20076.28B544.82M9.49%
Sep 30, 20065.74B397.18M7.44%
Sep 30, 20055.34B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Medline27.43B
Baxter International11.24B
Alcon10.19B
Intuitive Surgical10.06B
Solventum8.40B
ResMed5.40B
Hologic4.13B
The Cooper Companies4.09B
Revenue Rankings